Cited by 411Pluripotent Stem Cells ResearchCRISPR and Genetic EngineeringNeurogenesis and neuroplasticity mechanisms

Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease

Open access
Saha, Krishanu, Jaenisch, Rudolf·2009·Cell Stem Cell

Abstract

Reprogramming of human somatic cells uses readily accessible tissue, such as skin or blood, to generate embryonic-like induced pluripotent stem cells (iPSCs). This procedure has been applied to somatic cells from patients who are classified into a disease group, thus creating "disease-specific" iPSCs. Here, we examine the challenges and assumptions in creating a disease model from a single cell of the patient. Both the kinetics of disease onset and progression as well as the spatial localization of disease in the patient's body are challenges to disease modeling. New tools in genetic modification, reprogramming, biomaterials, and animal models can be used for addressing these challenges.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2009.11.009

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reprogramming without viral integration using plasmids or direct reprogramming protein delivery assays can solve the oncogene issue.

    “Nonetheless, reprogramming without viral integration with plasmids or direct reprogramming protein delivery assays can solve this issue [98,99].”

    From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [99]

    In “Strategies of deriving reprogramming factor-free hiPSCs” (page unavailable), the paper links integrated reprogramming factors, including c-Myc, to potential harm and describes plasmid and protein-based approaches that avoid or reduce genetic modification. But it says plasmid methods cannot completely rule out vector-fragment integration and protein transfection is exceedingly inefficient, so it does not establish that these methods solve the oncogene issue. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Stem cell models have faced inherent constraints in recapitulating in vivo cellular diversity and the organization of neuronal-glial interactions.

    “Despite advances in modeling Ts21, murine systems have limited translational relevance to human-specific aspects of neurodevelopment and cortical circuitry (7), whereas stem cell models have faced inherent constraints in recapitulating in vivo cellular diversity and the organization of neuronal-glial interactions (8, 9).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 108

  1. Aasen T Raya A Barrero MJ Garreta E Consiglio A Gonzalez F Vassena R Bilić J Pekarik V Tiscornia G 2008 Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes Nature Biotechnology 26 1276 1284 18931654
  2. Andersson ER Lendahl U 2009 Regenerative medicine: a 2009 overview J Intern Med 266 303 310 19765176
  3. Behringer RR 2007 Human-animal chimeras in biomedical research Cell Stem Cell 1 259 262 18371360
  4. Boland MJ Hazen JL Nazor KL Rodriguez AR Gifford W Martin G Kupriyanov S Baldwin KK 2009 Adult mice generated from induced pluripotent stem cells Nature 461 91 94 19672243
  5. Cantz T Bleidissel M Stehling M Schöler HR 2008 In vitro differentiation of reprogrammed murine somatic cells into hepatic precursor cells Biological Chemistry 389 889 896 18627307
  6. Carey BW Markoulaki S Hanna J Saha K Gao Q Mitalipova M Jaenisch R 2009 Reprogramming of murine and human somatic cells using a single polycistronic vector Proc Natl Acad Sci USA 106 157 162 19109433 PMC2629226
  7. Chan E Ratanasirintrawoot S Park I Manos P Loh Y Huo H Miller J Hartung O Rho J Ince T 2009 Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells Nature Biotechnology 10.1038/nbt.1580 19826408 · DOI
  8. Chang CW Lai YS Pawlik KM Liu K Sun CW Li C Schoeb TR Townes TM 2009 Polycistronic lentiviral vector for “hit and run” reprogramming of adult skin fibroblasts to induced pluripotent stem cells Stem Cells 27 1042 1049 19415770
  9. Chen M Tomkins DJ Auerbach W McKerlie C Youssoufian H Liu L Gan O Carreau M Auerbach A Groves T 1996 Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia Nature Genetics 12 448 451 8630504
  10. Choi KD Yu J Smuga-Otto K Salvagiotto G Rehrauer W Vodyanik M Thomson J Slukvin I 2009 Hematopoietic and endothelial differentiation of human induced pluripotent stem cells Stem Cells 27 559 567 19259936 PMC2931800
  11. Colman A Dreesen O 2009 Pluripotent stem cells and disease modeling Cell Stem Cell 5 244 247 19733533
  12. Costa M Dottori M Sourris K Jamshidi P Hatzistavrou T Davis R Azzola L Jackson S Lim SM Pera M 2007 A method for genetic modification of human embryonic stem cells using electroporation Nat Protoc 2 792 796 17446878
  13. Cummings BJ Uchida N Tamaki SJ Salazar DL Hooshmand M Summers R Gage FH Anderson AJ 2005 Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice Proc Natl Acad Sci USA 102 14069 14074 16172374 PMC1216836
  14. Daley GQ Lensch MW Jaenisch R Meissner A Plath K Yamanaka S 2009 Broader implications of defining standards for the pluripotency of iPSCs Cell Stem Cell 4 200 201 author reply 202 19265657
  15. Daley GQ Scadden DT 2008 Prospects for stem cell-based therapy Cell 132 544 548 18295571
  16. Davies B Morris T 1993 Physiological parameters in laboratory animals and humans Pharm Res 10 1093 1095 8378254
  17. Davis RP Ng ES Costa M Mossman AK Sourris K Elefanty AG Stanley EG 2008 Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors Blood 111 1876 1884 18032708
  18. Desbordes SC Placantonakis DG Ciro A Socci ND Lee G Djaballah H Studer L 2008 High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells Cell Stem Cell 2 602 612 18522853 PMC2756729
  19. Di Giorgio FP Boulting GL Bobrowicz S Eggan KC 2008 Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation Cell Stem Cell 3 637 648 19041780
  20. Dimos JT Rodolfa KT Niakan KK Weisenthal LM Mitsumoto H Chung W Croft GF Saphier G Leibel R Goland R 2008 Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 1218 1221 18669821
  21. Eiges R Urbach A Malcov M Frumkin T Schwartz T Amit A Yaron Y Eden A Yanuka O Benvenisty N 2007 Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos Cell Stem Cell 1 568 577 18371394
  22. Ellis J Bruneau BG Keller G Lemischka IR Nagy A Rossant J Srivastava D Zandstra PW Stanford WL 2009 Alternative induced pluripotent stem cell characterization criteria for in vitro applications Cell Stem Cell 4 198 199 author reply 202 19265656
  23. Freund C Mummery CL 2009 Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models J Cell Biochem 107 592 599 19449339
  24. Friese MA Jensen LT Willcox N Fugger L 2006 Humanized mouse models for organ-specific autoimmune diseases Curr Opin Immunol 18 704 709 17008081
  25. Fusaki N Ban H Nishiyama A Saeki K Hasegawa M 2009 Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome Proc Jpn Acad, Ser B 85 348 362 19838014 PMC3621571
  26. Gearhart J 1998 New potential for human embryonic stem cells Science 282 1061 1062 9841453
  27. Giorgetti A Montserrat N Aasen T Gonzalez F Rodríguez-Pizà I Vassena R Raya A Boué S Barrero MJ Corbella BA 2009 Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2 Cell Stem Cell 5 353 357 19796614 PMC2779776
  28. Giudice A Trounson A 2008 Genetic modification of human embryonic stem cells for derivation of target cells Cell Stem Cell 2 422 433 18462693
  29. Gonzalez F Barragan Monasterio M Tiscornia G Montserrat Pulido N Vassena R Batlle Morera L Rodriguez Piza I Izpisua Belmonte JC 2009 Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector Proc Natl Acad Sci USA 106 8918 8922 19458047 PMC2690033
  30. Green JJ Zhou BY Mitalipova MM Beard C Langer R Jaenisch R Anderson DG 2008 Nanoparticles for Gene Transfer to Human Embryonic Stem Cell Colonies Nano Letters 8 3126 3130 18754690 PMC3814161
  31. Grimm S 2004 The art and design of genetic screens: mammalian culture cells Nat Rev Genet 5 179 189 14970820
  32. Guilak F Cohen DM Estes BT Gimble JM Liedtke W Chen CS 2009 Control of stem cell fate by physical interactions with the extracellular matrix Cell Stem Cell 5 17 26 19570510 PMC2768283
  33. Guzman R Uchida N Bliss TM He D Christopherson KK Stellwagen D Capela A Greve J Malenka RC Moseley ME 2007 Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI Proc Natl Acad Sci USA 104 10211 10216 17553967 PMC1891235
  34. Haase A Olmer R Schwanke K Wunderlich S Merkert S Hess C Zweigerdt R Gruh I Meyer J Wagner S 2009 Generation of induced pluripotent stem cells from human cord blood Cell Stem Cell 5 434 441 19796623
  35. Hanna J Saha K Pando B van Zon J Lengner C Creyghton M van Oudenaarden A Jaenisch R 2009 Direct cell reprogramming is a stochastic process amenable to acceleration Nature 10.1038/nature08592 PMC2789972 19898493 · DOI
  36. Hanna J Wernig M Markoulaki S Sun CW Meissner A Cassady JP Beard C Brambrink T Wu LC Townes TM 2007 Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Science 318 1920 1923 18063756
  37. Hester ME Song S Miranda CJ Eagle A Schwartz PH Kaspar BK 2009 Two factor reprogramming of human neural stem cells into pluripotency PLoS ONE 4 e7044 19763260 PMC2739296
  38. Hockemeyer D Soldner F Beard C Gao Q Mitalipova M Dekelver RC Katibah GE Amora R Boydston EA Zeitler B 2009 Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases Nature Biotechnology 27 851 857 PMC4142824 19680244
  39. Hockemeyer D Soldner F Cook EG Gao Q Mitalipova M Jaenisch R 2008 A drug-inducible system for direct reprogramming of human somatic cells to pluripotency Cell Stem Cell 3 346 353 18786421 PMC4097107
  40. Hotta A Cheung AYL Farra N Vijayaragavan K Séguin CA Draper JS Pasceri P Maksakova IA Mager DL Rossant J 2009 Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency Nature Methods 6 370 376 19404254
  41. Huangfu D Maehr R Guo W Eijkelenboom A Snitow M Chen AE Melton DA 2008 Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds Nature biotechnology 26 795 797 PMC6334647 18568017
  42. Ichida J Blanchard J Lam K Son E Chung J Egli D Loh K Carter A Di Giorgio F Koszka K 2009 A Small-Molecule Inhibitor of Tgf-beta Signaling Replaces Sox2 in Reprogramming by Inducing Nanog Cell Stem Cell 10.1016/j.stem.2009.09.012 PMC3335195 19818703 · DOI · Paper page
  43. Irion S Luche H Gadue P Fehling HJ Kennedy M Keller G 2007 Identification and targeting of the ROSA26 locus in human embryonic stem cells Nature biotechnology 25 1477 1482 18037879
  44. Ishikawa F Yasukawa M Lyons B Yoshida S Miyamoto T Yoshimoto G Watanabe T Akashi K Shultz LD Harada M 2005 Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice Blood 106 1565 1573 15920010 PMC1895228
  45. Kaji K Norrby K Paca A Mileikovsky M Mohseni P Woltjen K 2009 Virus-free induction of pluripotency and subsequent excision of reprogramming factors Nature 458 771 775 19252477 PMC2667910
  46. Kang L Wang J Zhang Y Kou Z Gao S 2009 iPS cells can support full-term development of tetraploid blastocyst-complemented embryos Cell Stem Cell 5 135 138 19631602
  47. Khetani SR Bhatia SN 2008 Microscale culture of human liver cells for drug development Nature biotechnology 26 120 126 18026090
  48. Kim D Kim CH Moon JI Chung YG Chang MY Han BS Ko S Yang E Cha KY Lanza R 2009 Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins Cell Stem Cell 4 472 476 19481515 PMC2705327
  49. Kiuru M Boyer JL O’Connor TP Crystal RG 2009 Genetic control of wayward pluripotent stem cells and their progeny after transplantation Cell Stem Cell 4 289 300 19341619 PMC3254150
  50. Kneteman NM Mercer DF 2005 Mice with chimeric human livers: who says supermodels have to be tall? Hepatology 41 703 706 15789361
  51. Kuzmenkin A Liang H Xu G Pfannkuche K Eichhorn H Fatima A Luo H Saric T Wernig M Jaenisch R 2009 Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro The FASEB Journal 1 13 19703934
  52. Lacoste A Berenshteyn F Brivanlou AH 2009 An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells Cell Stem Cell 5 332 342 19733544
  53. Lee G Papapetrou E Kim H Chambers S Tomishima M Fasano C Ganat Y Menon J Shimizu F Viale A 2009 Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs Nature 10.1038/nature08320 PMC2784695 19693009 · DOI
  54. Loerch PM Lu T Dakin KA Vann JM Isaacs A Geula C Wang J Pan Y Gabuzda DH Li C 2008 Evolution of the aging brain transcriptome and synaptic regulation PLoS ONE 3 e3329 18830410 PMC2553198
  55. Lombardo A Genovese P Beausejour CM Colleoni S Lee YL Kim KA Ando D Urnov FD Galli C Gregory PD 2007 Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery Nature biotechnology 25 1298 1306 17965707
  56. Lowry WE Richter L Yachechko R Pyle AD Tchieu J Sridharan R Clark AT Plath K 2008 Generation of human induced pluripotent stem cells from dermal fibroblasts Proc Natl Acad Sci USA 105 2883 2888 18287077 PMC2268554
  57. Lyssiotis CA Foreman RK Staerk J Garcia M Mathur D Markoulaki S Hanna J Lairson LL Charette BD Bouchez LC 2009 Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4 Proc Natl Acad Sci USA 106 8912 8917 19447925 PMC2690053
  58. Maehr R Chen S Snitow M Ludwig T Yagasaki L Goland R Leibel RL Melton DA 2009 Generation of pluripotent stem cells from patients with type 1 diabetes Proc Natl Acad Sci USA 106 15768 15773 19720998 PMC2735559
  59. Marchetto MCN Muotri AR Mu Y Smith AM Cezar GG Gage FH 2008 Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells Cell Stem Cell 3 649 657 19041781
  60. Mateizel I De Temmerman N Ullmann U Cauffman G Sermon K Van de Velde H De Rycke M Degreef E Devroey P Liebaers I 2006 Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders Hum Reprod 21 503 511 16284066
  61. Mikkelsen TS Hanna J Zhang X Ku M Wernig M Schorderet P Bernstein BE Jaenisch R Lander ES Meissner A 2008 Dissecting direct reprogramming through integrative genomic analysis Nature 454 49 55 18509334 PMC2754827
  62. Moffat J Grueneberg DA Yang X Kim SY Kloepfer AM Hinkle G Piqani B Eisenhaure TM Luo B Grenier JK 2006 A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen Cell 124 1283 1298 16564017
  63. Muotri AR Nakashima K Toni N Sandler VM Gage FH 2005 Development of functional human embryonic stem cell-derived neurons in mouse brain Proc Natl Acad Sci USA 102 18644 18648 16352714 PMC1317971
  64. Nakagawa M Koyanagi M Tanabe K Takahashi K Ichisaka T Aoi T Okita K Mochiduki Y Takizawa N Yamanaka S 2008 Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nature biotechnology 26 101 106 18059259
  65. Narazaki G Uosaki H Teranishi M Okita K Kim B Matsuoka S Yamanaka S Yamashita JK 2008 Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells Circulation 118 498 506 18625891
  66. Nelson DL Gibbs RA 2004 Genetics. The critical region in trisomy 21 Science 306 619 621 15499000
  67. O’Malley J Woltjen K Kaji K 2009 New strategies to generate induced pluripotent stem cells Current Opinion in Biotechnology 10.1016/j.copbio.2009.09.005 19837580 · DOI
  68. Okita K Nakagawa M Hyenjong H Ichisaka T Yamanaka S 2008 Generation of mouse induced pluripotent stem cells without viral vectors Science 322 949 953 18845712
  69. Osakada F Jin ZB Hirami Y Ikeda H Danjyo T Watanabe K Sasai Y Takahashi M 2009 In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction Journal of Cell Science 122 3169 3179 19671662
  70. Park IH Zhao R West JA Yabuuchi A Huo H Ince TA Lerou PH Lensch MW Daley GQ 2008a Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 141 146 18157115
  71. Pickering SJ Minger SL Patel M Taylor H Black C Burns CJ Ekonomou A Braude PR 2005 Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis Reprod Biomed Online 10 390 397 15820050
  72. Placantonakis DG Tomishima MJ Lafaille F Desbordes SC Jia F Socci ND Viale A Lee H Harrison N Tabar V 2009 BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage Stem Cells 27 521 532 19074416
  73. Raya A Rodríguez-Pizà I Guenechea G Vassena R Navarro S Barrero MJ Consiglio A Castellà M Río P Sleep E 2009 Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells Nature 460 53 59 19483674 PMC2720823
  74. Reeves RH Irving NG Moran TH Wohn A Kitt C Sisodia SS Schmidt C Bronson RT Davisson MT 1995 A mouse model for Down syndrome exhibits learning and behaviour deficits Nature Genetics 11 177 184 7550346
  75. Reubinoff BE Pera MF Fong CY Trounson A Bongso A 2000 Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro Nature biotechnology 18 399 404 10748519
  76. Rubin LL 2008 Stem cells and drug discovery: the beginning of a new era? Cell 132 549 552 18295572
  77. Schenke-Layland K Rhodes KE Angelis E Butylkova Y Heydarkhan-Hagvall S Gekas C Zhang R Goldhaber JI Mikkola HK Plath K 2008 Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages Stem Cells 26 1537 1546 18450826 PMC2873147
  78. Shi Y Do JT Desponts C Hahm HS Schöler HR Ding S 2008 A combined chemical and genetic approach for the generation of induced pluripotent stem cells Cell Stem Cell 2 525 528 18522845
  79. Shultz LD Ishikawa F Greiner DL 2007 Humanized mice in translational biomedical research Nat Rev Immunol 7 118 130 17259968
  80. Shultz LD Lyons BL Burzenski LM Gott B Chen X Chaleff S Kotb M Gillies SD King M Mangada J 2005 Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells J Immunol 174 6477 6489 15879151
  81. Smith-Arica JR Thomson AJ Ansell R Chiorini J Davidson B McWhir J 2003 Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors Cloning and Stem Cells 5 51 62 12713701
  82. Soldner F Hockemeyer D Beard C Gao Q Bell GW Cook EG Hargus G Blak A Cooper O Mitalipova M 2009 Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 964 977 19269371 PMC2787236
  83. Sothern RB Gruber SA 1994 Further commentary: physiological parameters in laboratory animals and humans Pharm Res 11 349 350 8165201
  84. Spits C Mateizel I Geens M Mertzanidou A Staessen C Vandeskelde Y Van der Elst J Liebaers I Sermon K 2008 Recurrent chromosomal abnormalities in human embryonic stem cells Nature Biotechnology 26 1361 1363 19029912
  85. Sridharan R Tchieu J Mason MJ Yachechko R Kuoy E Horvath S Zhou Q Plath K 2009 Role of the Murine Reprogramming Factors in the Induction of Pluripotency Cell 136 364 377 19167336 PMC3273494
  86. Stadtfeld M Nagaya M Utikal J Weir G Hochedlinger K 2008 Induced pluripotent stem cells generated without viral integration Science 322 945 949 18818365 PMC3987909
  87. Stockwell BR 2004 Exploring biology with small organic molecules Nature 432 846 854 15602550 PMC3165172
  88. Sun N Panetta NJ Gupta DM Wilson KD Lee A Jia F Hu S Cherry AM Robbins RC Longaker MT 2009 Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells Proc Natl Acad Sci USA 106 15720 15725 19805220 PMC2739869
  89. Takahashi K Tanabe K Ohnuki M Narita M Ichisaka T Tomoda K Yamanaka S 2007 Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors Cell 131 861 872 18035408
  90. Taura D Noguchi M Sone M Hosoda K Mori E Okada Y Takahashi K Homma K Oyamada N Inuzuka M 2009 Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells FEBS Lett 583 1029 1033 19250937
  91. Thomson JA Itskovitz-Eldor J Shapiro SS Waknitz MA Swiergiel JJ Marshall VS Jones JM 1998 Embryonic stem cell lines derived from human blastocysts Science 282 1145 1147 9804556
  92. Urbach A Benvenisty N 2009 Studying early lethality of 45,XO (Turner’s syndrome) embryos using human embryonic stem cells PLoS ONE 4 e4175 19137066 PMC2613558
  93. Urbach A Schuldiner M Benvenisty N 2004 Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells Stem Cells 22 635 641 15277709
  94. Wernig M Zhao JP Pruszak J Hedlund E Fu D Soldner F Broccoli V Constantine-Paton M Isacson O Jaenisch R 2008 Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease Proc Natl Acad Sci USA 105 5856 5861 18391196 PMC2311361
  95. Woltjen K Michael IP Mohseni P Desai R Mileikovsky M Hämäläinen R Cowling R Wang W Liu P Gertsenstein M 2009 piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells Nature 458 766 770 19252478 PMC3758996
  96. Xia X Zhang Y Zieth CR Zhang SC 2007 Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner Stem Cells and Development 16 167 176 17348812 PMC2801347
  97. Xu D Alipio Z Fink LM Adcock DM Yang J Ward DC Ma Y 2009 Phenotypic correction of murine hemophilia A using an iPS cell-based therapy Proc Natl Acad Sci USA 106 808 813 19139414 PMC2630078
  98. Xu Y Shi Y Ding S 2008 A chemical approach to stem-cell biology and regenerative medicine Nature 453 338 344 18480815
  99. Yamada KM Cukierman E 2007 Modeling tissue morphogenesis and cancer in 3D Cell 130 601 610 17719539
  100. Ye L Chang JC Lin C Sun X Yu J Kan YW 2009a Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases Proc Natl Acad Sci USA 106 9826 9830 10.1073/pnas.0904689106 19482945 PMC2701047 · DOI
  101. Ye Z Zhan H Mali P Dowey S Williams DM Jang Y-Y Dang CV Spivak JL Moliterno AR Cheng L 2009b Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Blood 10.1182/blood-2009-04-217406 PMC2798863 19797525 · DOI
  102. Yu J Hu K Smuga-Otto K Tian S Stewart R Slukvin II Thomson JA 2009 Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences Science 1172482 1172482 PMC2758053 19325077
  103. Yu J Vodyanik MA Smuga-Otto K Antosiewicz-Bourget J Frane JL Tian S Nie J Jonsdottir GA Ruotti V Stewart R 2007 Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells Science 318 1917 1920 18029452
  104. Zhao X-y Li W Lv Z Liu L Tong M Hai T Hao J Guo C-l Ma Q-w Wang L 2009 iPS cells produce viable mice through tetraploid complementation Nature 461 86 90 19672241
  105. Zhao Y Yin X Qin H Zhu F Liu H Yang W Zhang Q Xiang C Hou P Song Z 2008 Two supporting factors greatly improve the efficiency of human iPSC generation Cell Stem Cell 3 475 479 18983962
  106. Zhou H Wu S Joo JY Zhu S Han DW Lin T Trauger S Bien G Yao S Zhu Y 2009 Generation of induced pluripotent stem cells using recombinant proteins Cell Stem Cell 4 381 384 19398399 PMC10182564
  107. Zou J Maeder ML Mali P Pruett-Miller SM Thibodeau-Beganny S Chou BK Chen G Ye Z Park IH Daley GQ 2009 Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells Cell Stem Cell 5 97 110 19540188 PMC2720132
  108. Zwaka TP Thomson JA 2003 Homologous recombination in human embryonic stem cells Nature Biotechnology 21 319 321 12577066

Cited by

Sorted by citations

Authors
Saha, K., & Jaenisch, R.
Affiliations
Whitehead Institute for Biomedical Research (US)
Corresponding author
Jaenisch, Rudolf
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2009-12
Volume
5
Issue
6
Pages
584-595
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2101736621
Cited by
411
References
6
Citations by year
2026: 3 · 2025: 11 · 2024: 7 · 2023: 15 · 2022: 11 · 2021: 9 · 2020: 15 · 2019: 25 · 2018: 27 · 2017: 11 · 2016: 24 · 2015: 19 · 2014: 39 · 2013: 45 · 2012: 57
FWCI
3.83
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders
  • National Institutes of Health (2r01ca084198-10)
  • U.S. Public Health Service (R01-HDO45022)
  • National Cancer Institute (R01-CA084198, R01CA087869, R37CA084198)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD045022)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
human induced pluripotent stem cells, disease modeling, somatic cell reprogramming, disease onset and progression, genetic modification, biomaterials, animal models, patient-derived iPSCs
MeSH terms
Animals, Cell Differentiation, Disease Models, Animal, Humans, Cell Culture Techniques, Genomics, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review